Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

476
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
476
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

279
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
279
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

154
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
154
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

189
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
189
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

287
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
287
Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

36.1K
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
36.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficient Radiosynthesis of <sup>99m</sup>Tc-Amygdalin for Tumor Imaging Using a <sup>99</sup>Mo/<sup>99m</sup>Tc Generator Based on Alumina Doped With Terbium Oxide.

Archiv der Pharmazie·2026
Same author

Re-evaluation of "Peptic" duodenitis: A review of 622 consecutive duodenal biopsies.

Annals of diagnostic pathology·2026
Same author

KMT2D depletion promotes KRAS-induced pancreatic carcinogenesis independent of TP53.

The Journal of biological chemistry·2026
Same author

Correction: Efficacy, safety, route of administration of midazolam and diazepam for pediatric status epilepticus: systematic review, meta-analysis, and trial sequential analysis.

Pediatric research·2026
Same author

Retraction notice to 'A comparative study between propofol and dexmedetomidine as sedative agents during performing transcatheter aortic valve implantation' [Journal of Clinical Anesthesia 32 (2016) 242-247].

Journal of clinical anesthesia·2026
Same author

Dual-Screw Fixation for Chronic Syndesmotic Injury: A Case Report.

Journal of orthopaedic case reports·2026

Related Experiment Video

Updated: Jan 5, 2026

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

1.5K

Fatty Liver Disease: A Practical Approach.

Mohamed Mostafa1, Amrou Abdelkader1, John J Evans1

  • 1From the Department of Pathology, Medical College of Wisconsin, Milwaukee.

Archives of Pathology & Laboratory Medicine
|October 12, 2019
PubMed
Summary
This summary is machine-generated.

Fatty liver disease evaluation is critical. This guide offers a structured approach to analyzing liver biopsies, distinguishing simple steatosis from steatohepatitis for better patient management and risk assessment.

More Related Videos

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

16.7K
Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.6K

Related Experiment Videos

Last Updated: Jan 5, 2026

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

1.5K
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

16.7K
Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.6K

Area of Science:

  • Hepatology
  • Pathology
  • Gastroenterology

Background:

  • Fatty liver disease is a prevalent condition in liver pathology practice.
  • Differentiating simple steatosis from steatohepatitis is crucial due to the latter's long-term risks, including cirrhosis and hepatocellular carcinoma.
  • Accurate diagnosis impacts patient follow-up and management strategies.

Purpose of the Study:

  • To present a systematic, stepwise method for evaluating liver biopsies with significant steatosis (≥5% of parenchyma).
  • To guide pathologists in identifying key histological features for accurate diagnosis.
  • To provide a framework for consistent and standardized reporting of fatty liver disease in biopsies.

Main Methods:

  • Review of liver biopsies demonstrating fatty liver disease from clinical practice.
  • Analysis of relevant scientific literature on fatty liver disease and liver biopsy interpretation.
  • Development of a structured approach incorporating degree of steatosis, ballooning degeneration, lobular inflammation, and fibrosis assessment.

Main Results:

  • A comprehensive stepwise approach for liver biopsy evaluation in steatosis is detailed.
  • The approach includes assessment of steatosis grade, ballooning, inflammation, and fibrosis.
  • Examples, potential pitfalls, and differential diagnoses are provided to aid interpretation.

Conclusions:

  • Effective evaluation necessitates careful histologic examination and clinical correlation (medications, nutrition, alcohol).
  • Uniform reporting, including the use of the nonalcoholic steatohepatitis Clinical Research Network Activity Score, is recommended.
  • The proposed stepwise approach enhances diagnostic accuracy and consistency in managing fatty liver disease.